Overview

Drug of Abuse Testing Market Introduction

Drug of Abuse Testing Market is estimated to value over USD 13.2 billion by 2027 end with a CAGR of over 8.2% during the forecast period 2020 to 2027.

Drug of abuse testing is a process of identification of illegal drugs in blood, urine, saliva and others. The drugs include cocaine, opiates, marijuana, methamphetamine, benzodiazepine, methadone, ecstasy, amphetamine, barbiturates, PCP and others. Drug of abuse testing is a qualitative process and mostly performed in clinical settings. In drug of abuse testing, sample collection is a critical process and requires high integrity. Urine is the most preferable sample for the drug of abuse testing due to the high window of detection and 75% of the clinical settings use urine for testing. Saliva is the second preferable sample for the drug of abuse testing due to a simpler process, but it has a narrow window of detection.

Increasing illegal use of drugs for recreational purposes has fuelled the growth of drug of abuse testing market. Further, increasing government pressure to control the illicit drug usage among the adult population has led to the potential growth of the global drug of abuse testing market. Government agencies along with public organizations are taking a direct part in controlling drug of abuse and launched many programs in both the public & private sectors. Changing regulatory scenarios has created significant opportunities for a drug of abuse testing manufacturers. Along with these, technology has integrated the existing manual operations and boosted the penetration. Technology has led to the development of a fully automated process with a wide range of drug detection. Others factors like increasing awareness boosted the robust growth of the market.

North America Drug of Abuse Testing market witnessed significant share due to stringent federal policies. It was followed by the European drug of abuse testing market with stable market growth over the forecast period. Asia Pacific and Latin America Drug of Abuse Testing market has witnessed fastest CAGR due to increasing awareness.

Major market players include Thermo Fisher Scientific, SYNLAB, Siemens Healthcare Private Limited, Roche Diagnostics, Drägerwerk AG & Co. KGaA, Beckman Coulter, Inc., Abbott Laboratories Express Diagnostics International Inc., Shimadzu Corporation, Alere Inc. and Laboratory Corporation of America Holdings.

Drug of Abuse Testing Market

Drug of Abuse Testing Market Segmentations:

By Product & Services

Analyzers
Consumables
Rapid Testing Devices
Laboratory Services

By Test Type

Immunoassay Test
Point-of-Care Tests
Chromatography Tests

By Sample Type

Urine
Blood
Saliva
Breath

By End User

Pathology Laboratories
Hospitals
Rehabilitation Centers
Federal Agencies
Forensic Laboratories
Clinics
Others

By Region

Europe
North America
APAC
Latin America
Rest of World

Competitive Landscape:

Tier 1 players- established companies in the market with major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Takeaways

Growth prospects
SWOT analysis
Key trends
Key data-points

Objectives of the Study:

To provide with an exhaustive analysis on the global drug of abuse testing market on the basis of test type, sample type, end-user and region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and overall market
To predict market size, in five key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies